Commonwealth Coat of Arms of Australia

 

PB 53 of 2025

 

National Health (Supply of Pharmaceutical Benefits—Under Co-payment Data and Claims for Payment) Amendment (ACSS Payment Advances) Rules 2025

 

I, Sarah Norris, as delegate of the Minister for Health and Ageing, make the following Rules.

Dated 27 May 2025

Sarah Norris

Assistant Secretary

Pharmacy Branch

Technology Assessment and Access Division

Department of Health, Disability and Ageing

 

1  Name

2  Commencement

3  Authority

4  Schedules

Schedule 1—Amendments

National Health (Supply of Pharmaceutical Benefits—Under Co‑payment Data and Claims for Payment) Rules 2022

 

 

  1.     This instrument is the National Health (Supply of Pharmaceutical Benefits—Under Co-payment Data and Claims for Payment) Amendment (ACSS Payment Advances) Rules 2025.
  2.     This instrument may also be cited as PB 53 of 2025.
  1.     Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

 

Commencement information

Column 1

Column 2

Column 3

Provisions

Commencement

Date/Details

1.  The whole of this instrument

1 July 2025.

1 July 2025

Note:  This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.

  1.     Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

  This instrument is made under subsection 99AAA(8) of the National Health Act 1953.

  Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.

  1.         Subsection 12(2) (note)

Repeal the note, substitute:

Note: Advance payments are permitted in accordance with section 99AB of the Act, on account of amounts that may become payable under section 99 or section 99AAAA of the Act. Advance payments are associated with claims made using the Claims Transmission System.  

  1.         Paragraphs 13(2)(b) and (c)

Repeal the paragraphs (not including the example), substitute:

(b)  a statement of account is given to the approved supplier in respect of each claim for payment.

  1.         Subsection 13(3)

Repeal the subsection (not including the note), substitute:

  1.     Information included in a statement of account about ACSS payments made in respect of ACSS eligible supplies made before 1 July 2025:
  1.     is not required to relate to a particular claim period; and
  2.    may be included in a statement of account that relates to supplies of pharmaceutical benefits made in different claim periods.